Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y2RM
|
||||
Former ID |
DNC011426
|
||||
Drug Name |
ISOGUANOSINE
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551229] | ||
Structure |
Download2D MOL |
||||
Formula |
C10H13N5O5
|
||||
Canonical SMILES |
C1=NC2=C(NC(=O)N=C2N1C3C(C(C(O3)CO)O)O)N
|
||||
InChI |
1S/C10H13N5O5/c11-7-4-8(14-10(19)13-7)15(2-12-4)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19)/t3-,5-,6-,9-/m1/s1
|
||||
InChIKey |
MIKUYHXYGGJMLM-UUOKFMHZSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A2b receptor | Target Info | Inhibitor | [551229] | |
Adenosine A1 receptor | Target Info | Inhibitor | [551229] | ||
Adenosine A2a receptor | Target Info | Inhibitor | [551229] | ||
KEGG Pathway | Rap1 signaling pathway | ||||
Calcium signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Vascular smooth muscle contraction | |||||
Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
cAMP signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Morphine addictionhsa04015:Rap1 signaling pathway | |||||
Parkinson's disease | |||||
Alcoholism | |||||
Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.